DARUNAVIR 800 MG

DARUNAVIR 800 MG was reported 6179 times

DARUNAVIR 800 MG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HIV LIPODYSTROPHY 7 0.7000
1 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 82 0.6357
2 SUBEPENDYMAL CYST 6 0.5455
3 GLUCOCORTICOIDS INCREASED 9 0.4500
4 HIV ASSOCIATED NEPHROPATHY 14 0.2745
5 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 20 0.1802
6 RETROPERITONEAL DISORDER 4 0.1739
7 PERITONEAL CYST 9 0.1667
8 AIDS ENCEPHALOPATHY 9 0.1552
9 SCROTAL CYST 13 0.1529
10 CSF HIV ESCAPE SYNDROME 21 0.1522
11 PERITONEAL THICKENING 4 0.1429
12 FLOPPY EYELID SYNDROME 5 0.1429
13 PULMONARY SEQUESTRATION 7 0.1273
14 ENZYME ACTIVITY INCREASED 4 0.1250
15 MITOCHONDRIAL TOXICITY 101 0.1230
16 BLADDER AGENESIS 9 0.1216
17 CONGENITAL INTESTINAL MALFORMATION 14 0.1207
18 CLOACAL EXSTROPHY 7 0.1186
19 BLOOD HIV RNA 6 0.1154
20 CD4 LYMPHOCYTES ABNORMAL 23 0.1095
21 AQUEDUCTAL STENOSIS 4 0.1053
22 HEMIATAXIA 4 0.1053
23 ECTOPIC KIDNEY 10 0.1053
24 HALLUCINATION, SYNAESTHETIC 6 0.1034
25 ACUTE HAEMORRHAGIC CONJUNCTIVITIS 3 0.1000
26 ANAL CANCER STAGE 0 3 0.0968
27 FOETAL GROWTH ABNORMALITY 15 0.0955
28 KAPOSI SARCOMA INFLAMMATORY CYTOKINE SYNDROME 5 0.0847
29 LIPODYSTROPHY ACQUIRED 146 0.0687
30 ABORTION OF ECTOPIC PREGNANCY 8 0.0667
31 LARYNGOMALACIA 22 0.0657
32 AORTIC VALVE ATRESIA 4 0.0635
33 VIROLOGIC FAILURE 328 0.0609
34 ADJUSTED CALCIUM INCREASED 3 0.0566
35 GASTROINTESTINAL DISORDER CONGENITAL 6 0.0566
36 VIRAL MUTATION IDENTIFIED 200 0.0542
37 HIV VIRAEMIA 11 0.0524
38 CD4 LYMPHOCYTES DECREASED 104 0.0485
39 BLOOD HIV RNA INCREASED 86 0.0474
40 DYSDIADOCHOKINESIS 8 0.0468
41 AIDS RELATED COMPLICATION 3 0.0462
42 MENINGOENCEPHALITIS VIRAL 8 0.0452
43 CAUDAL REGRESSION SYNDROME 7 0.0449
44 POST TRANSPLANT DISTAL LIMB SYNDROME 9 0.0443
45 GASTROSCHISIS 21 0.0441
46 VENTRICULAR HYPOPLASIA 11 0.0440
47 CRANIAL NERVE PALSIES MULTIPLE 6 0.0429
48 BRAIN STEM STROKE 20 0.0406
49 GENITALIA EXTERNAL AMBIGUOUS 7 0.0405
50 SECONDARY SYPHILIS 4 0.0404
51 SUPERIOR MESENTERIC ARTERY SYNDROME 9 0.0404
52 TERATOGENICITY 12 0.0397
53 ADRENAL SUPPRESSION 33 0.0391
54 MECONIUM STAIN 6 0.0390
55 CONGENITAL PULMONARY VALVE DISORDER 4 0.0388
56 CONGENITAL GENITAL MALFORMATION 6 0.0375
57 SKULL MALFORMATION 24 0.0373
58 ANION GAP ABNORMAL 10 0.0373
59 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 12 0.0358
60 CONGENITAL CEREBRAL CYST 4 0.0357
61 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 175 0.0351
62 VIRAL LOAD 6 0.0347
63 NEW ONSET DIABETES AFTER TRANSPLANTATION 6 0.0347
64 LEISHMANIASIS 10 0.0345
65 NEONATAL RESPIRATORY ARREST 5 0.0342
66 RENAL TUBULAR DYSFUNCTION 19 0.0336
67 GASTROINTESTINAL MALFORMATION 7 0.0335
68 EXTRAOCULAR MUSCLE PARESIS 15 0.0327
69 TESTICULAR MASS 7 0.0320
70 MENINGOCELE 5 0.0318
71 BILE OUTPUT INCREASED 3 0.0316
72 INTERFERON GAMMA RELEASE ASSAY POSITIVE 5 0.0305
73 GENOTYPE DRUG RESISTANCE TEST POSITIVE 31 0.0302
74 ALPHA 1 FOETOPROTEIN ABNORMAL 3 0.0300
75 CONGENITAL HEART VALVE DISORDER 7 0.0294
76 HYPERADRENOCORTICISM 8 0.0291
77 VIRAL LOAD ABNORMAL 5 0.0286
78 CHOLESTASIS OF PREGNANCY 13 0.0283
79 ATRIOVENTRICULAR SEPTAL DEFECT 13 0.0277
80 ACUTE HEPATITIS C 5 0.0273
81 AMNIOTIC BAND SYNDROME 3 0.0273
82 TETHERED CORD SYNDROME 6 0.0271
83 CENTRAL NERVOUS SYSTEM INFLAMMATION 9 0.0271
84 SYPHILIS 19 0.0261
85 PLAGIOCEPHALY 13 0.0261
86 CEREBRAL VENTRICLE DILATATION 30 0.0260
87 GENITAL DISCHARGE 6 0.0251
88 CENTRAL HYPOTHYROIDISM 8 0.0242
89 OESOPHAGEAL ATRESIA 15 0.0240
90 PATHOGEN RESISTANCE 214 0.0235
91 AORTA HYPOPLASIA 6 0.0231
92 HYPERPROTEINAEMIA 6 0.0228
93 CONDUCTIVE DEAFNESS 7 0.0218
94 MONKEYPOX 6 0.0217
95 CENTRAL OBESITY 16 0.0217
96 OPHTHALMOPLEGIA 34 0.0215
97 DEVELOPMENTAL COORDINATION DISORDER 4 0.0214
98 CENTRAL NERVOUS SYSTEM VIRAL INFECTION 3 0.0210
99 BETA 2 MICROGLOBULIN URINE INCREASED 3 0.0210
100 RENAL ANEURYSM 5 0.0208
101 COMPLICATION OF DELIVERY 6 0.0208
102 RELAPSING FEVER 6 0.0208
103 CSF TEST ABNORMAL 10 0.0199
104 CONGENITAL AORTIC STENOSIS 4 0.0197
105 SPINA BIFIDA 41 0.0197
106 URINARY TRACT INFLAMMATION 7 0.0194
107 PLEOCYTOSIS 11 0.0189
108 EXOMPHALOS 10 0.0186
109 CYSTITIS NONINFECTIVE 25 0.0186
110 IMMUNE RECONSTITUTION SYNDROME 24 0.0186
111 ACUTE ON CHRONIC LIVER FAILURE 4 0.0185
112 TRISOMY 21 23 0.0183
113 BREAST HAEMORRHAGE 6 0.0182
114 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 4 0.0181
115 TRANCE 6 0.0164
116 GENE MUTATION 32 0.0162
117 ENCEPHALOCELE 4 0.0161
118 LEFT VENTRICULAR ENLARGEMENT 4 0.0157
119 LIPOEDEMA 6 0.0153
120 UMBILICAL CORD ABNORMALITY 8 0.0152
121 ACUTE HEPATITIS B 5 0.0151
122 ANAL ATRESIA 8 0.0150
123 HEPATITIS B DNA INCREASED 10 0.0148
124 SPINE MALFORMATION 5 0.0144
125 FIBROUS HISTIOCYTOMA 5 0.0142
126 SUDDEN INFANT DEATH SYNDROME 7 0.0142
127 MICROGNATHIA 7 0.0140
128 VIRAL LOAD INCREASED 54 0.0139
129 CHYLOTHORAX 10 0.0139
130 PORTAL VENOUS GAS 5 0.0138
131 VIRAEMIA 19 0.0137
132 MESENTERIC ARTERY THROMBOSIS 5 0.0130
133 POLYDACTYLY 15 0.0129
134 CD4 LYMPHOCYTES INCREASED 3 0.0129
135 LIPOHYPERTROPHY 8 0.0129
136 FAT TISSUE DECREASED 5 0.0128
137 LOW BIRTH WEIGHT BABY 96 0.0121
138 MENINGOMYELOCELE 7 0.0117
139 ACQUIRED IMMUNODEFICIENCY SYNDROME 6 0.0116
140 HELLP SYNDROME 7 0.0114
141 COARCTATION OF THE AORTA 11 0.0114
142 HYPERMETABOLISM 6 0.0113
143 DELAYED GRAFT FUNCTION 8 0.0113
144 DRUG RESISTANCE 289 0.0112
145 CUSHINGOID 36 0.0112
146 WEANING FAILURE 4 0.0110
147 SKIN STRIAE 16 0.0107
148 PRIMARY BILIARY CHOLANGITIS 5 0.0106
149 DYSLIPIDAEMIA 54 0.0106
150 DIAPHRAGMATIC DISORDER 8 0.0105
151 EYELID PTOSIS 105 0.0103
152 COCCIDIOIDOMYCOSIS 12 0.0101
153 PUNCTURE SITE HAEMORRHAGE 7 0.0099
154 HEART TRANSPLANT REJECTION 10 0.0096
155 ANTICOAGULATION DRUG LEVEL INCREASED 3 0.0093
156 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 8 0.0092
157 ENCEPHALITIS CYTOMEGALOVIRUS 4 0.0091
158 FANCONI SYNDROME ACQUIRED 16 0.0091
159 COMPULSIONS 6 0.0090
160 BLOOD TRIGLYCERIDES DECREASED 3 0.0089
161 PSYCHOMOTOR RETARDATION 25 0.0089
162 GLYCOSURIA 12 0.0089
163 CONGENITAL FOOT MALFORMATION 4 0.0088
164 SECONDARY ADRENOCORTICAL INSUFFICIENCY 13 0.0086
165 LIMB REDUCTION DEFECT 5 0.0086
166 RENAL TUBULAR DISORDER 24 0.0085
167 FANCONI SYNDROME 12 0.0085
168 CRYSTAL NEPHROPATHY 5 0.0084
169 CONGENITAL HYDRONEPHROSIS 6 0.0084
170 VISCERAL LEISHMANIASIS 6 0.0083
171 MYCOBACTERIUM AVIUM COMPLEX INFECTION 22 0.0082
172 AORTIC VALVE SCLEROSIS 6 0.0082
173 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 27 0.0082
174 VERBAL ABUSE 4 0.0082
175 INFECTIVE ANEURYSM 4 0.0081
176 MENINGITIS VIRAL 11 0.0080
177 BLOOD CORTISOL DECREASED 5 0.0078
178 ECTOPIC PREGNANCY 24 0.0078
179 MICROCEPHALY 10 0.0078
180 NEUROPSYCHIATRIC SYMPTOMS 7 0.0078
181 CEREBELLAR SYNDROME 17 0.0078
182 FOETAL GROWTH RESTRICTION 47 0.0077
183 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 5 0.0077
184 CHRONIC ALLOGRAFT NEPHROPATHY 6 0.0077
185 ACQUIRED GENE MUTATION 10 0.0076
186 RETROGRADE EJACULATION 6 0.0076
187 LYMPHOCELE 5 0.0075
188 MULTIPLE-DRUG RESISTANCE 23 0.0074
189 TOXOPLASMOSIS 8 0.0074
190 HYPOPLASTIC LEFT HEART SYNDROME 5 0.0074
191 LIPOATROPHY 7 0.0074
192 FOETAL DEATH 38 0.0073
193 HIV INFECTION 22 0.0073
194 LIVE BIRTH 61 0.0073
195 GINGIVAL HYPERTROPHY 11 0.0072
196 ANAL CANCER 7 0.0072
197 TYPE III IMMUNE COMPLEX MEDIATED REACTION 4 0.0072
198 MYCOBACTERIAL INFECTION 12 0.0070
199 AMNIOTIC CAVITY INFECTION 5 0.0069
200 SMALL FOR DATES BABY 34 0.0068
201 ABDOMINAL SEPSIS 6 0.0068
202 GENERALISED ANXIETY DISORDER 10 0.0068
203 PNEUMONIA PNEUMOCOCCAL 10 0.0067
204 COMPLICATION OF PREGNANCY 5 0.0066
205 PRURIGO 6 0.0065
206 HYPERTRICHOSIS 12 0.0065
207 MEGACOLON 10 0.0064
208 PREMATURE LABOUR 36 0.0064
209 PYELOCALIECTASIS 6 0.0063
210 ANAEMIA NEONATAL 3 0.0062
211 FOETAL EXPOSURE DURING PREGNANCY 500 0.0061
212 POSTPARTUM HAEMORRHAGE 8 0.0059
213 ABORTION INDUCED 55 0.0058
214 HEPATITIS CHOLESTATIC 35 0.0058
215 PREMATURE BABY 173 0.0057
216 MENINGITIS CRYPTOCOCCAL 10 0.0057
217 PRE-ECLAMPSIA 27 0.0057
218 FOETAL HEART RATE DECELERATION ABNORMALITY 4 0.0057
219 BLOOD ALKALINE PHOSPHATASE ABNORMAL 5 0.0056
220 LIP DISCOLOURATION 7 0.0055
221 WHITE MATTER LESION 7 0.0055
222 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 43 0.0055
223 LIPIDS ABNORMAL 4 0.0055
224 LABELLED DRUG-DRUG INTERACTION ISSUE 8 0.0055
225 GLOMERULONEPHRITIS MINIMAL LESION 4 0.0055
226 PREMATURE DELIVERY 87 0.0055
227 NEPHROPATHY TOXIC 61 0.0054
228 STILLBIRTH 26 0.0054
229 HEART DISEASE CONGENITAL 19 0.0054
230 PARAINFLUENZAE VIRUS INFECTION 8 0.0053
231 PUPILS UNEQUAL 6 0.0052
232 PULMONARY HYPOPLASIA 4 0.0051
233 ACIDOSIS HYPERCHLORAEMIC 3 0.0051
234 INDURATION 9 0.0050
235 CEREBRAL ISCHAEMIA 26 0.0050
236 DILATED CARDIOMYOPATHY 5 0.0049
237 DYSBIOSIS 4 0.0049
238 METABOLIC SYNDROME 8 0.0049
239 GLOMERULAR FILTRATION RATE INCREASED 4 0.0048
240 CSF PROTEIN INCREASED 4 0.0048
241 ADRENAL INSUFFICIENCY 58 0.0048
242 CARDIAC VENTRICULAR THROMBOSIS 6 0.0046
243 CHOREA 8 0.0046
244 ENDOCRINE OPHTHALMOPATHY 4 0.0046
245 HYDROCEPHALUS 25 0.0046
246 GENITAL HERPES 7 0.0046
247 PREMATURE RUPTURE OF MEMBRANES 11 0.0046
248 LARGE FOR DATES BABY 4 0.0045
249 SUBSTANCE USE 7 0.0045
250 ANOGENITAL WARTS 4 0.0045
251 THERAPEUTIC PRODUCT CROSS-REACTIVITY 4 0.0045
252 DRUG INTERACTION 704 0.0044
253 ABORTION SPONTANEOUS 176 0.0044
254 PLACENTAL DISORDER 4 0.0042
255 ANAEMIA MACROCYTIC 9 0.0042
256 HYPERTRIGLYCERIDAEMIA 24 0.0041
257 PENILE SWELLING 5 0.0041
258 DUODENAL PERFORATION 4 0.0041
259 HIGH DENSITY LIPOPROTEIN INCREASED 4 0.0040
260 DIPLOPIA 104 0.0040
261 VENTRICULAR HYPERTROPHY 10 0.0040
262 LIPIDS INCREASED 8 0.0040
263 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 35 0.0040
264 AUTONOMIC NEUROPATHY 4 0.0039
265 ATRIAL SEPTAL DEFECT 32 0.0038
266 ALANINE AMINOTRANSFERASE ABNORMAL 8 0.0038
267 HEPATITIS B REACTIVATION 12 0.0038
268 ABORTION 11 0.0038
269 TINEA PEDIS 6 0.0038
270 EXPOSURE DURING PREGNANCY 231 0.0037
271 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 4 0.0036
272 DRUG LEVEL INCREASED 60 0.0036
273 PNEUMOCYSTIS JIROVECI PNEUMONIA 8 0.0036
274 PORTAL HYPERTENSION 11 0.0036
275 TREATMENT NONCOMPLIANCE 194 0.0035
276 RENAL COLIC 8 0.0035
277 COMPLICATIONS OF TRANSPLANTED KIDNEY 8 0.0035
278 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 29 0.0035
279 MATERNAL EXPOSURE DURING PREGNANCY 313 0.0035
280 MILIARIA 6 0.0035
281 BENIGN PROSTATIC HYPERPLASIA 18 0.0035
282 ABDOMINAL LYMPHADENOPATHY 3 0.0035
283 RENAL INFARCT 5 0.0035
284 VASCULAR STENT THROMBOSIS 7 0.0034
285 OSTEOLYSIS 7 0.0034
286 PORTAL VEIN THROMBOSIS 11 0.0034
287 HEPATITIS C 41 0.0034
288 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 4 0.0033
289 CYTOLYTIC HEPATITIS 11 0.0033
290 ENCEPHALITIS VIRAL 4 0.0033
291 PALLIATIVE CARE 5 0.0033
292 OESOPHAGEAL CANDIDIASIS 13 0.0033
293 PARADOXICAL DRUG REACTION 12 0.0033
294 PREMATURE SEPARATION OF PLACENTA 5 0.0032
295 BLOOD LACTIC ACID INCREASED 17 0.0032
296 RETINOPATHY 12 0.0032
297 AORTIC STENOSIS 11 0.0032
298 EUGLYCAEMIC DIABETIC KETOACIDOSIS 13 0.0031
299 CACHEXIA 16 0.0031
300 CONGENITAL ANOMALY 24 0.0031
301 CYTOMEGALOVIRUS CHORIORETINITIS 6 0.0031
302 DRUG LEVEL DECREASED 31 0.0030
303 HIRSUTISM 4 0.0030
304 NEUTROPENIC SEPSIS 21 0.0029
305 URINARY HESITATION 7 0.0029
306 CLUSTER HEADACHE 4 0.0029
307 PSYCHOTIC SYMPTOM 6 0.0029
308 PHYSICAL ASSAULT 6 0.0029
309 TRANSPLANT FAILURE 7 0.0029
310 TUMOUR LYSIS SYNDROME 25 0.0028
311 BONE DEMINERALISATION 3 0.0028
312 HEPATITIS B 17 0.0028
313 PNEUMOCYSTIS JIROVECII PNEUMONIA 28 0.0028
314 BEHAVIOUR DISORDER 15 0.0028
315 BLADDER DILATATION 3 0.0028
316 INTRACRANIAL ANEURYSM 11 0.0027
317 TREATMENT FAILURE 224 0.0027
318 HEPATITIS TOXIC 7 0.0027
319 NEUROLOGICAL SYMPTOM 15 0.0026
320 VENTRICULAR SEPTAL DEFECT 15 0.0026
321 LIP BLISTER 7 0.0026
322 RESPIRATORY RATE DECREASED 8 0.0025
323 INTERMITTENT CLAUDICATION 4 0.0025
324 HYPERPHAGIA 10 0.0025
325 JC VIRUS INFECTION 4 0.0025
326 MATERNAL DRUGS AFFECTING FOETUS 19 0.0025
327 ENCEPHALITIS 17 0.0025
328 AUTOIMMUNE HEPATITIS 17 0.0024
329 ESCHERICHIA SEPSIS 7 0.0024
330 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 9 0.0024
331 BLOOD BILIRUBIN ABNORMAL 3 0.0023
332 PULMONARY TUBERCULOSIS 10 0.0023
333 PSYCHOMOTOR SKILLS IMPAIRED 6 0.0023
334 ENTEROCOCCAL INFECTION 11 0.0023
335 ACROCHORDON 3 0.0023
336 HISTOPLASMOSIS 4 0.0023
337 TALIPES 7 0.0023
338 CAESAREAN SECTION 26 0.0022
339 ORAL CANDIDIASIS 29 0.0022
340 DERMATITIS EXFOLIATIVE 11 0.0022
341 RENAL TUBULAR NECROSIS 21 0.0021
342 HYPERBILIRUBINAEMIA 22 0.0021
343 MECHANICAL VENTILATION 4 0.0021
344 BRAIN INJURY 21 0.0021
345 ENTERITIS 13 0.0020
346 HEPATITIS ACUTE 13 0.0020
347 CLOSTRIDIUM DIFFICILE COLITIS 21 0.0020
348 ACUTE MYOCARDIAL INFARCTION 58 0.0020
349 CALCULUS URINARY 3 0.0019
350 HEPATOSPLENOMEGALY 5 0.0019
351 HYPERURICAEMIA 8 0.0019
352 RASH MACULO-PAPULAR 43 0.0019
353 MUCORMYCOSIS 5 0.0019
354 PULSELESS ELECTRICAL ACTIVITY 8 0.0019
355 BLOOD PROLACTIN INCREASED 9 0.0019
356 RENAL IMPAIRMENT 160 0.0019
357 SUBCUTANEOUS ABSCESS 9 0.0019
358 VULVOVAGINAL DRYNESS 6 0.0019
359 ANGINA UNSTABLE 12 0.0018
360 ODYNOPHAGIA 11 0.0018
361 LYMPHOCYTE COUNT INCREASED 6 0.0018
362 CERVICAL DYSPLASIA 4 0.0018
363 OSTEOPOROSIS 74 0.0018
364 ILEUS PARALYTIC 8 0.0018
365 NAIL DISCOLOURATION 7 0.0018
366 HYPERCHOLESTEROLAEMIA 17 0.0018
367 HYPOPHOSPHATAEMIA 13 0.0018
368 RESPIRATORY SYMPTOM 5 0.0018
369 PROTEINURIA 33 0.0017
370 DEPRESSION SUICIDAL 6 0.0017
371 CAROTID ARTERY STENOSIS 6 0.0017
372 PERIPHERAL VENOUS DISEASE 7 0.0017
373 VENTRICULAR FIBRILLATION 19 0.0017
374 GROWTH RETARDATION 5 0.0017
375 BLOOD BILIRUBIN INCREASED 45 0.0017
376 END STAGE RENAL DISEASE 30 0.0016
377 AMYLASE INCREASED 6 0.0016
378 MYOPATHY 14 0.0016
379 CARDIAC MURMUR 14 0.0016
380 TENDON INJURY 6 0.0016
381 BLOOD CHOLESTEROL DECREASED 3 0.0016
382 EPSTEIN-BARR VIRUS INFECTION 10 0.0016
383 HYPERLIPIDAEMIA 19 0.0016
384 OSTEONECROSIS 52 0.0016
385 TRISMUS 8 0.0015
386 GLOMERULAR FILTRATION RATE DECREASED 19 0.0015
387 MALABSORPTION 8 0.0015
388 SKIN ODOUR ABNORMAL 6 0.0015
389 GLUCOSE TOLERANCE IMPAIRED 9 0.0015
390 SEROTONIN SYNDROME 29 0.0015
391 NYSTAGMUS 8 0.0015
392 NEPHROPATHY 14 0.0015
393 ANAL ABSCESS 8 0.0015
394 NEUROTOXICITY 26 0.0015
395 PRODUCT LABEL ISSUE 10 0.0015
396 NORMAL NEWBORN 8 0.0015
397 HAEMARTHROSIS 13 0.0014
398 OSTEOPENIA 22 0.0014
399 LUNG CONSOLIDATION 4 0.0014
400 BRAIN OEDEMA 18 0.0014
401 LOW DENSITY LIPOPROTEIN INCREASED 11 0.0014
402 ANTIPSYCHOTIC DRUG LEVEL INCREASED 4 0.0014
403 HEPATIC CYTOLYSIS 18 0.0014
404 POOR PERIPHERAL CIRCULATION 6 0.0014
405 HEPATIC ENCEPHALOPATHY 13 0.0014
406 HERPES VIRUS INFECTION 8 0.0014
407 CORONARY ARTERY DISEASE 42 0.0014
408 SOCIAL AVOIDANT BEHAVIOUR 8 0.0014
409 BLOOD PHOSPHORUS DECREASED 5 0.0014
410 CHOLESTASIS 26 0.0014
411 HISTIOCYTOSIS HAEMATOPHAGIC 4 0.0013
412 VITAMIN D DEFICIENCY 13 0.0013
413 STATUS EPILEPTICUS 15 0.0013
414 LACTIC ACIDOSIS 43 0.0013
415 VARICES OESOPHAGEAL 4 0.0013
416 ACUTE HEPATIC FAILURE 18 0.0013
417 CENTRAL NERVOUS SYSTEM LESION 18 0.0013
418 DRUG EXPOSURE DURING PREGNANCY 44 0.0013
419 PROCEDURAL HAEMORRHAGE 5 0.0013
420 INTESTINAL ISCHAEMIA 7 0.0013
421 CYTOMEGALOVIRUS INFECTION 21 0.0013
422 HEPATOTOXICITY 28 0.0013
423 TOXIC EPIDERMAL NECROLYSIS 19 0.0012
424 TRANSPLANT REJECTION 10 0.0012
425 RHABDOMYOLYSIS 52 0.0012
426 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 32 0.0012
427 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0012
428 POSTURE ABNORMAL 4 0.0012
429 JAUNDICE 33 0.0012
430 ACUTE PSYCHOSIS 3 0.0012
431 ACUTE CORONARY SYNDROME 10 0.0012
432 OLIGOHYDRAMNIOS 4 0.0012
433 PNEUMONIA BACTERIAL 11 0.0012
434 BLOOD TRIGLYCERIDES INCREASED 21 0.0012
435 FACE OEDEMA 20 0.0012
436 TOXIC ENCEPHALOPATHY 6 0.0012
437 HEPATIC PAIN 5 0.0012
438 DIFFUSE LARGE B-CELL LYMPHOMA 9 0.0012
439 ELECTROCARDIOGRAM QT PROLONGED 42 0.0012
440 AORTIC ARTERIOSCLEROSIS 3 0.0012
441 FOOT FRACTURE 22 0.0012
442 ASCITES 34 0.0012
443 RENAL FAILURE ACUTE 48 0.0011
444 PARKINSONISM 11 0.0011
445 PANCYTOPENIA 63 0.0011
446 CYTOMEGALOVIRUS VIRAEMIA 5 0.0011
447 ACUTE KIDNEY INJURY 172 0.0011
448 ALCOHOL ABUSE 3 0.0011
449 ECONOMIC PROBLEM 17 0.0011
450 RHINITIS 9 0.0011
451 URINE ABNORMALITY 5 0.0011
452 SPINAL COMPRESSION FRACTURE 9 0.0011
453 LOCALISED OEDEMA 5 0.0011
454 TRANSAMINASES INCREASED 24 0.0011
455 HYDRONEPHROSIS 8 0.0011
456 LIVER FUNCTION TEST ABNORMAL 31 0.0011
457 ANHEDONIA 28 0.0011
458 PULMONARY HYPERTENSION 22 0.0011
459 FACIAL PARALYSIS 9 0.0011
460 DRUG-INDUCED LIVER INJURY 33 0.0011
461 PSEUDOMONAS INFECTION 9 0.0010
462 MENINGITIS 7 0.0010
463 ANURIA 9 0.0010
464 GASTROINTESTINAL TOXICITY 5 0.0010
465 EYELID OEDEMA 12 0.0010
466 HORMONE LEVEL ABNORMAL 5 0.0010
467 IMMUNOSUPPRESSION 9 0.0010
468 PURPURA 9 0.0010
469 HYPERVOLAEMIA 5 0.0010
470 CEREBRAL ATROPHY 4 0.0010
471 MYOSITIS 9 0.0010
472 BONE MARROW DISORDER 3 0.0010
473 ATRIOVENTRICULAR BLOCK SECOND DEGREE 3 0.0010
474 MULTIPLE ORGAN DYSFUNCTION SYNDROME 28 0.0010
475 METABOLIC ACIDOSIS 31 0.0010
476 DERMATITIS BULLOUS 7 0.0010
477 RASH PUSTULAR 7 0.0010
478 GASTROENTERITIS 14 0.0010
479 SWELLING OF EYELID 6 0.0010
480 ONYCHOMADESIS 4 0.0010
481 FOOD CRAVING 5 0.0009
482 POISONING DELIBERATE 9 0.0009
483 POST PROCEDURAL HAEMORRHAGE 11 0.0009
484 BLOOD CREATINE PHOSPHOKINASE INCREASED 27 0.0009
485 NERVOUS SYSTEM DISORDER 29 0.0009
486 ATAXIA 11 0.0009
487 RASH GENERALISED 24 0.0009
488 TENDON PAIN 7 0.0009
489 ASPERGILLUS INFECTION 6 0.0009
490 HEPATIC STEATOSIS 17 0.0009
491 DRUG LEVEL BELOW THERAPEUTIC 5 0.0009
492 STEVENS-JOHNSON SYNDROME 20 0.0009
493 ALANINE AMINOTRANSFERASE INCREASED 55 0.0009
494 ABNORMAL LOSS OF WEIGHT 6 0.0009
495 HAEMATURIA 30 0.0009
496 LYMPHADENOPATHY 31 0.0009
497 APLASIA PURE RED CELL 3 0.0009
498 AGRANULOCYTOSIS 16 0.0009
499 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
500 COVID-19 PNEUMONIA 10 0.0008
501 GESTATIONAL DIABETES 4 0.0008
502 C-REACTIVE PROTEIN INCREASED 30 0.0008
503 ASTHMATIC CRISIS 3 0.0008
504 ORAL DISORDER 6 0.0008
505 HEPATOMEGALY 8 0.0008
506 VITREOUS FLOATERS 8 0.0008
507 EOSINOPHILIA 14 0.0008
508 ERYSIPELAS 4 0.0008
509 TOXICITY TO VARIOUS AGENTS 134 0.0008
510 MYOCARDIAL ISCHAEMIA 9 0.0008
511 ASPARTATE AMINOTRANSFERASE INCREASED 42 0.0008
512 SHOCK 18 0.0008
513 HYPOALBUMINAEMIA 6 0.0008
514 GASTROINTESTINAL CARCINOMA 7 0.0008
515 CARDIOPULMONARY FAILURE 3 0.0008
516 HERPES SIMPLEX 5 0.0008
517 SPLENOMEGALY 9 0.0008
518 BLOOD CREATININE INCREASED 50 0.0008
519 NEPHROLITHIASIS 35 0.0008
520 FOLLICULITIS 8 0.0008
521 RENAL PAIN 8 0.0008
522 ARTERIOSCLEROSIS 7 0.0007
523 PANCREATITIS 39 0.0007
524 BLOOD URINE PRESENT 14 0.0007
525 ACUTE RESPIRATORY DISTRESS SYNDROME 13 0.0007
526 THROMBOCYTOPENIA 82 0.0007
527 POLYURIA 6 0.0007
528 MATERNAL EXPOSURE BEFORE PREGNANCY 5 0.0007
529 HEPATIC FAILURE 22 0.0007
530 BLOOD ALKALINE PHOSPHATASE INCREASED 18 0.0007
531 MUSCLE INJURY 6 0.0007
532 FEBRILE NEUTROPENIA 48 0.0007
533 DIZZINESS POSTURAL 7 0.0007
534 DIABETES MELLITUS 55 0.0007
535 EOSINOPHIL COUNT INCREASED 6 0.0007
536 HAEMODIALYSIS 6 0.0007
537 ACUTE PULMONARY OEDEMA 4 0.0007
538 HEPATIC CANCER 17 0.0007
539 LYMPHOPENIA 10 0.0007
540 SINUS TACHYCARDIA 10 0.0007
541 ABSCESS LIMB 3 0.0007
542 CARDIAC FAILURE CHRONIC 3 0.0007
543 HEPATITIS 18 0.0007
544 LIVER INJURY 17 0.0007
545 ANAEMIA 132 0.0007
546 DELIRIUM 24 0.0007
547 FAECES SOFT 5 0.0007
548 HYPOVOLAEMIA 4 0.0007
549 BLOOD CREATINE INCREASED 3 0.0007
550 RESPIRATORY RATE INCREASED 6 0.0007
551 MYOCLONUS 8 0.0007
552 PROTHROMBIN TIME PROLONGED 4 0.0007
553 SEPTIC SHOCK 29 0.0007
554 MENTAL DISORDER 29 0.0007
555 HYPERGLYCAEMIA 24 0.0007
556 RESPIRATORY FAILURE 48 0.0007
557 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0007
558 LIVER DISORDER 29 0.0007
559 ENCEPHALOPATHY 16 0.0007
560 CANDIDA INFECTION 11 0.0007
561 PREGNANCY 13 0.0006
562 GENERALISED OEDEMA 8 0.0006
563 PHARYNGITIS 8 0.0006
564 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
565 TUBULOINTERSTITIAL NEPHRITIS 12 0.0006
566 HEPATIC CIRRHOSIS 12 0.0006
567 TORSADE DE POINTES 5 0.0006
568 NIGHTMARE 22 0.0006
569 NERVE INJURY 7 0.0006
570 ATRIAL FLUTTER 5 0.0006
571 MYDRIASIS 8 0.0006
572 ERECTILE DYSFUNCTION 16 0.0006
573 THROMBOSIS 50 0.0006
574 REFUSAL OF TREATMENT BY PATIENT 4 0.0006
575 HICCUPS 5 0.0006
576 CHRONIC KIDNEY DISEASE 46 0.0006
577 CORONAVIRUS INFECTION 4 0.0006
578 EMPHYSEMA 6 0.0006
579 BRONCHIECTASIS 4 0.0006
580 ANGIOEDEMA 26 0.0006
581 HYPOKALAEMIA 27 0.0006
582 INFARCTION 4 0.0006
583 PARANOIA 10 0.0006
584 PANCREATITIS ACUTE 13 0.0006
585 PYELONEPHRITIS 5 0.0006
586 NOCTURIA 7 0.0006
587 PANIC ATTACK 21 0.0006
588 HYPERTRANSAMINASAEMIA 4 0.0006
589 BONE DENSITY DECREASED 18 0.0006
590 HYPERKALAEMIA 20 0.0006
591 HALLUCINATION, AUDITORY 9 0.0006
592 HEPATOCELLULAR INJURY 8 0.0006
593 PNEUMONIA ASPIRATION 14 0.0006
594 HAEMOLYTIC ANAEMIA 5 0.0006
595 SPINAL FRACTURE 11 0.0005
596 MAJOR DEPRESSION 4 0.0005
597 CARDIAC ARREST 45 0.0005
598 AGITATION 40 0.0005
599 GENERALISED TONIC-CLONIC SEIZURE 9 0.0005
600 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
601 CEREBRAL DISORDER 4 0.0005
602 MALNUTRITION 6 0.0005
603 HEPATIC FUNCTION ABNORMAL 20 0.0005
604 TYPE 2 DIABETES MELLITUS 18 0.0005
605 NEURALGIA 13 0.0005
606 DYSARTHRIA 20 0.0005
607 IMMUNE SYSTEM DISORDER 7 0.0005
608 SQUAMOUS CELL CARCINOMA 5 0.0005
609 COLITIS 20 0.0005
610 LIPASE INCREASED 4 0.0005
611 MULTI-ORGAN FAILURE 9 0.0005
612 RENAL FAILURE CHRONIC 4 0.0005
613 DEVICE RELATED INFECTION 8 0.0005
614 BLOOD URIC ACID INCREASED 3 0.0005
615 METASTASES TO LUNG 6 0.0005
616 LYMPHOMA 8 0.0005
617 DRUG TOXICITY 7 0.0005
618 DECREASED IMMUNE RESPONSIVENESS 5 0.0005
619 PSYCHOTIC DISORDER 15 0.0005
620 BLOOD IRON DECREASED 6 0.0005
621 BACTERAEMIA 6 0.0005
622 MASS 7 0.0005
623 SALIVARY HYPERSECRETION 5 0.0005
624 RASH PRURITIC 27 0.0005
625 MUCOSAL INFLAMMATION 13 0.0005
626 MYOCARDIAL INFARCTION 86 0.0005
627 CHROMATURIA 11 0.0005
628 MULTIPLE FRACTURES 8 0.0005
629 HYPERCALCAEMIA 6 0.0005
630 NEUROPATHY PERIPHERAL 45 0.0005
631 INCONTINENCE 5 0.0005
632 SUDDEN DEATH 5 0.0005
633 HEMIPARESIS 8 0.0005
634 MOVEMENT DISORDER 15 0.0005
635 SEPSIS 52 0.0005
636 SKIN HYPERPIGMENTATION 4 0.0005
637 DYSPHAGIA 44 0.0005
638 PSYCHOLOGICAL TRAUMA 4 0.0005
639 MUSCLE STRAIN 4 0.0005
640 RENAL FAILURE 61 0.0005
641 EPILEPSY 14 0.0005
642 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
643 COGNITIVE DISORDER 21 0.0004
644 NEUTROPENIA 61 0.0004
645 MYALGIA 76 0.0004
646 OSTEOMYELITIS 8 0.0004
647 OBESITY 7 0.0004
648 RESTLESSNESS 16 0.0004
649 RETINAL DETACHMENT 4 0.0004
650 RESPIRATORY DISTRESS 12 0.0004
651 ELECTROLYTE IMBALANCE 5 0.0004
652 HYPOPHAGIA 11 0.0004
653 PHOTOPHOBIA 8 0.0004
654 DIALYSIS 6 0.0004
655 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
656 HAEMATOTOXICITY 4 0.0004
657 PRODUCT PRESCRIBING ERROR 10 0.0004
658 SUBDURAL HAEMATOMA 6 0.0004
659 CEREBRAL HAEMORRHAGE 15 0.0004
660 PRURITUS GENERALISED 9 0.0004
661 GENERAL PHYSICAL HEALTH DETERIORATION 48 0.0004
662 SWELLING FACE 27 0.0004
663 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
664 PYREXIA 142 0.0004
665 NO THERAPEUTIC RESPONSE 5 0.0004
666 SEIZURE 47 0.0004
667 OEDEMA 22 0.0004
668 NO ADVERSE EVENT 73 0.0004
669 ADVERSE EVENT 37 0.0004
670 LOCAL SWELLING 7 0.0004
671 ARRHYTHMIA 19 0.0004
672 PULMONARY EMBOLISM 38 0.0004
673 ABNORMAL DREAMS 11 0.0004
674 DERMATITIS ALLERGIC 5 0.0004
675 APHASIA 12 0.0004
676 DEPRESSED MOOD 21 0.0004
677 PERITONITIS BACTERIAL 4 0.0004
678 CONTRAINDICATED PRODUCT ADMINISTERED 12 0.0004
679 DIABETES MELLITUS INADEQUATE CONTROL 7 0.0004
680 TACHYCARDIA 35 0.0004
681 THIRST 7 0.0004
682 LIP SWELLING 13 0.0004
683 PERITONITIS 8 0.0004
684 APNOEA 3 0.0004
685 BASAL CELL CARCINOMA 6 0.0004
686 BEDRIDDEN 5 0.0004
687 DEPRESSED LEVEL OF CONSCIOUSNESS 15 0.0004
688 ADVERSE DRUG REACTION 34 0.0004
689 CONFUSIONAL STATE 61 0.0004
690 BACTERIAL INFECTION 7 0.0004
691 QUALITY OF LIFE DECREASED 5 0.0004
692 MENTAL IMPAIRMENT 9 0.0004
693 MUSCLE TIGHTNESS 6 0.0004
694 DEPRESSION 83 0.0004
695 MELAENA 8 0.0004
696 INJECTION SITE NODULE 4 0.0004
697 VENTRICULAR TACHYCARDIA 6 0.0004
698 PRESCRIBED OVERDOSE 7 0.0004
699 FOOT DEFORMITY 4 0.0004
700 EAR PAIN 7 0.0004
701 ORAL PAIN 8 0.0004
702 GASTROINTESTINAL DISORDER 32 0.0004
703 CELLULITIS 18 0.0004
704 CARDIOVASCULAR DISORDER 9 0.0004
705 OSTEOARTHRITIS 15 0.0004
706 MITRAL VALVE INCOMPETENCE 4 0.0004
707 HEPATIC ENZYME INCREASED 24 0.0004
708 SYNCOPE 35 0.0003
709 SLEEP DISORDER 24 0.0003
710 WHITE BLOOD CELL COUNT INCREASED 13 0.0003
711 DISEASE RECURRENCE 16 0.0003
712 CARDIOTOXICITY 3 0.0003
713 COLON CANCER 5 0.0003
714 CARDIO-RESPIRATORY ARREST 14 0.0003
715 INFECTION 48 0.0003
716 SCHIZOPHRENIA 4 0.0003
717 ANKLE FRACTURE 5 0.0003
718 DEHYDRATION 43 0.0003
719 VOMITING 150 0.0003
720 FRACTURE 6 0.0003
721 GASTRIC ULCER 6 0.0003
722 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
723 DRUG INTOLERANCE 30 0.0003
724 ATELECTASIS 3 0.0003
725 ANOREXIA 4 0.0003
726 HIATUS HERNIA 4 0.0003
727 BLOOD POTASSIUM INCREASED 5 0.0003
728 SUICIDAL IDEATION 28 0.0003
729 KIDNEY INFECTION 6 0.0003
730 SPEECH DISORDER 16 0.0003
731 ABDOMINAL PAIN 71 0.0003
732 TINNITUS 14 0.0003
733 METASTASES TO BONE 5 0.0003
734 SARS-COV-2 TEST POSITIVE 4 0.0003
735 HYPERTENSION 64 0.0003
736 DIARRHOEA 195 0.0003
737 HYPONATRAEMIA 17 0.0003
738 LEUKOPENIA 15 0.0003
739 CONDITION AGGRAVATED 91 0.0003
740 SKIN EXFOLIATION 25 0.0003
741 RASH 129 0.0003
742 RIB FRACTURE 6 0.0003
743 CORONARY ARTERY OCCLUSION 4 0.0003
744 PRODUCT USE IN UNAPPROVED INDICATION 72 0.0003
745 MUSCULAR WEAKNESS 33 0.0003
746 WEIGHT DECREASED 81 0.0003
747 THERAPY NON-RESPONDER 13 0.0003
748 EMOTIONAL DISTRESS 35 0.0003
749 MENTAL STATUS CHANGES 8 0.0003
750 ORTHOSTATIC HYPOTENSION 5 0.0003
751 WEIGHT INCREASED 64 0.0003
752 BLISTER 16 0.0003
753 DYSPEPSIA 28 0.0003
754 HYPOXIA 10 0.0003
755 OFF LABEL USE 248 0.0003
756 SKIN DISCOLOURATION 13 0.0003
757 DRUG ERUPTION 5 0.0003
758 UPPER RESPIRATORY TRACT INFECTION 13 0.0003
759 HOSPITALISATION 43 0.0003
760 RENAL DISORDER 13 0.0003
761 DISORIENTATION 11 0.0003
762 HYPERTHYROIDISM 4 0.0003
763 DEATH 238 0.0003
764 INJECTION SITE REACTION 19 0.0003
765 BONE DISORDER 5 0.0003
766 EYE DISORDER 9 0.0003
767 STAPHYLOCOCCAL INFECTION 9 0.0003
768 DYSURIA 10 0.0003
769 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 13 0.0003
770 URINARY RETENTION 9 0.0003
771 IMMUNODEFICIENCY 4 0.0003
772 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 14 0.0003
773 ABDOMINAL DISTENSION 28 0.0003
774 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
775 BONE LOSS 4 0.0003
776 GASTRITIS 7 0.0003
777 CEREBROVASCULAR ACCIDENT 45 0.0003
778 PROSTATE CANCER 21 0.0003
779 HYPOTENSION 52 0.0003
780 HAEMORRHOIDS 5 0.0003
781 BLOOD PRESSURE DECREASED 17 0.0003
782 SKIN LESION 7 0.0003
783 RESPIRATORY ARREST 7 0.0003
784 DISABILITY 5 0.0003
785 PNEUMOTHORAX 4 0.0003
786 RASH ERYTHEMATOUS 12 0.0003
787 INTENTIONAL OVERDOSE 16 0.0002
788 HYPERHIDROSIS 32 0.0002
789 HYPOGLYCAEMIA 12 0.0002
790 SUICIDE ATTEMPT 15 0.0002
791 ASTHENIA 93 0.0002
792 VERTIGO 15 0.0002
793 CEREBRAL INFARCTION 6 0.0002
794 BLINDNESS 10 0.0002
795 CONVULSION 14 0.0002
796 ANGINA PECTORIS 7 0.0002
797 COAGULOPATHY 4 0.0002
798 SKIN DISORDER 8 0.0002
799 DYSPNOEA EXERTIONAL 9 0.0002
800 DERMATITIS 5 0.0002
801 BLOOD CHOLESTEROL INCREASED 11 0.0002
802 LIVER FUNCTION TEST INCREASED 5 0.0002
803 COMA 11 0.0002
804 THERAPEUTIC RESPONSE DECREASED 14 0.0002
805 RESPIRATORY TRACT INFECTION 6 0.0002
806 PLEURAL EFFUSION 14 0.0002
807 ASTHMA 26 0.0002
808 HAEMORRHAGE 24 0.0002
809 DEAFNESS 6 0.0002
810 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
811 COMPLETED SUICIDE 19 0.0002
812 FEMUR FRACTURE 7 0.0002
813 LETHARGY 13 0.0002
814 MALAISE 99 0.0002
815 EAR INFECTION 6 0.0002
816 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
817 SYNOVITIS 4 0.0002
818 THROAT TIGHTNESS 6 0.0002
819 ANXIETY 63 0.0002
820 CHEST PAIN 41 0.0002
821 INSOMNIA 58 0.0002
822 INJECTION SITE MASS 8 0.0002
823 POLLAKIURIA 9 0.0002
824 FEELING HOT 13 0.0002
825 HYPOCALCAEMIA 4 0.0002
826 DECREASED APPETITE 49 0.0002
827 CARDIOGENIC SHOCK 3 0.0002
828 PALPITATIONS 24 0.0002
829 ORAL HERPES 4 0.0002
830 PNEUMONIA 65 0.0002
831 EPISTAXIS 15 0.0002
832 RASH MACULAR 7 0.0002
833 AMNESIA 13 0.0002
834 HYPERSENSITIVITY 37 0.0002
835 CARDIAC FAILURE CONGESTIVE 16 0.0002
836 INTENTIONAL SELF-INJURY 4 0.0002
837 MEDICATION ERROR 11 0.0002
838 NEUTROPHIL COUNT DECREASED 8 0.0002
839 ERYTHEMA 40 0.0002
840 ANAPHYLACTIC SHOCK 5 0.0002
841 COVID-19 34 0.0002
842 HAEMATOMA 5 0.0002
843 WRONG TECHNIQUE IN DRUG USAGE PROCESS 7 0.0002
844 SWELLING 18 0.0002
845 NERVOUSNESS 10 0.0002
846 MOUTH ULCERATION 4 0.0002
847 SOMNOLENCE 38 0.0002
848 EATING DISORDER 4 0.0002
849 NAUSEA 148 0.0002
850 RECTAL HAEMORRHAGE 8 0.0002
851 NIGHT SWEATS 6 0.0002
852 OVERDOSE 40 0.0002
853 MOOD ALTERED 5 0.0002
854 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
855 VISUAL ACUITY REDUCED 6 0.0002
856 DRUG INEFFECTIVE 238 0.0002
857 AGGRESSION 9 0.0002
858 RASH PAPULAR 4 0.0002
859 ARTHRITIS 14 0.0002
860 PARAESTHESIA 28 0.0002
861 ABNORMAL BEHAVIOUR 7 0.0002
862 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
863 HEADACHE 109 0.0002
864 DYSKINESIA 7 0.0002
865 GAIT DISTURBANCE 32 0.0002
866 HAEMOGLOBIN DECREASED 17 0.0002
867 ACCIDENTAL OVERDOSE 6 0.0002
868 NECK PAIN 9 0.0002
869 DISEASE PROGRESSION 19 0.0002
870 DRY MOUTH 13 0.0002
871 HYPOTHYROIDISM 5 0.0002
872 INFLAMMATION 8 0.0002
873 UNRESPONSIVE TO STIMULI 4 0.0002
874 FATIGUE 120 0.0002
875 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
876 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
877 HYPOAESTHESIA 23 0.0002
878 SEDATION 4 0.0002
879 CHOLELITHIASIS 5 0.0002
880 FUNGAL INFECTION 5 0.0001
881 GASTROOESOPHAGEAL REFLUX DISEASE 12 0.0001
882 BRONCHITIS 11 0.0001
883 INTENTIONAL PRODUCT USE ISSUE 13 0.0001
884 ANGER 5 0.0001
885 OEDEMA PERIPHERAL 18 0.0001
886 DISCOMFORT 9 0.0001
887 LIMB INJURY 4 0.0001
888 HALLUCINATION 11 0.0001
889 PRODUCT USE ISSUE 27 0.0001
890 GASTROINTESTINAL HAEMORRHAGE 12 0.0001
891 DEMENTIA 4 0.0001
892 INJURY 10 0.0001
893 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
894 FLATULENCE 8 0.0001
895 ABDOMINAL PAIN UPPER 29 0.0001
896 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 10 0.0001
897 HYPERSOMNIA 4 0.0001
898 ARTHRALGIA 58 0.0001
899 PRODUCT SUBSTITUTION ISSUE 8 0.0001
900 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
901 INTENTIONAL PRODUCT MISUSE 12 0.0001
902 MALIGNANT NEOPLASM PROGRESSION 14 0.0001
903 CHILLS 16 0.0001
904 LABORATORY TEST ABNORMAL 4 0.0001
905 COUGH 38 0.0001
906 FALL 45 0.0001
907 RENAL INJURY 4 0.0001
908 DYSGEUSIA 10 0.0001
909 RESPIRATORY DISORDER 4 0.0001
910 DRUG ABUSE 11 0.0001
911 ABDOMINAL DISCOMFORT 22 0.0001
912 MEMORY IMPAIRMENT 18 0.0001
913 CHEST DISCOMFORT 13 0.0001
914 MUSCULOSKELETAL STIFFNESS 11 0.0001
915 MOBILITY DECREASED 9 0.0001
916 TREMOR 20 0.0001
917 GAIT INABILITY 4 0.0001
918 ABDOMINAL PAIN LOWER 3 0.0001
919 DYSPNOEA 67 0.0001
920 CARDIAC DISORDER 11 0.0001
921 SINUSITIS 12 0.0001
922 PERIPHERAL SWELLING 18 0.0001
923 BRADYCARDIA 6 0.0001
924 PAIN 69 0.0001
925 BACK PAIN 26 0.0001
926 URINARY TRACT INFECTION 19 0.0001
927 DISTURBANCE IN ATTENTION 6 0.0001
928 MYELOSUPPRESSION 4 0.0001
929 DRUG EFFECT INCOMPLETE 4 0.0001
930 VISION BLURRED 15 0.0001
931 MUSCLE SPASMS 20 0.0001
932 CONSTIPATION 23 0.0001
933 PRODUCTIVE COUGH 5 0.0001
934 PRURITUS 40 0.0001
935 CONTUSION 10 0.0001
936 PLATELET COUNT DECREASED 11 0.0001
937 CATARACT 6 0.0001
938 EXTRA DOSE ADMINISTERED 4 0.0001
939 OROPHARYNGEAL PAIN 9 0.0001
940 DIZZINESS 47 0.0001
941 RHINORRHOEA 6 0.0001
942 BALANCE DISORDER 8 0.0001
943 ATRIAL FIBRILLATION 9 0.0001
944 DEEP VEIN THROMBOSIS 6 0.0001
945 WHITE BLOOD CELL COUNT DECREASED 10 0.0001
946 PAIN IN EXTREMITY 27 0.0001
947 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
948 URTICARIA 15 0.0001
949 EYE PAIN 5 0.0001
950 CARDIAC FAILURE 7 0.0001
951 HERPES ZOSTER 5 0.0001
952 BONE PAIN 5 0.0001
953 BLOOD GLUCOSE INCREASED 16 0.0001
954 IRRITABILITY 5 0.0001
955 HOT FLUSH 6 0.0001
956 FLUID RETENTION 4 0.0001
957 LOSS OF CONSCIOUSNESS 10 0.0001
958 PRODUCT DOSE OMISSION 5 0.0001
959 MUSCULOSKELETAL PAIN 4 0.0001
960 NEOPLASM MALIGNANT 5 0.0001
961 INCORRECT DOSE ADMINISTERED 17 0.0001
962 OXYGEN SATURATION DECREASED 4 0.0001
963 FEELING ABNORMAL 17 0.0001
964 DRY SKIN 9 0.0001
965 ACNE 5 0.0001
966 INFLUENZA 7 0.0001
967 BLOOD PRESSURE INCREASED 9 0.0001
968 BURNING SENSATION 4 0.0001
969 VISUAL IMPAIRMENT 7 0.0001
970 UNDERDOSE 4 0.0001
971 ANAPHYLACTIC REACTION 3 0.0001
972 PRODUCT QUALITY ISSUE 7 0.0001
973 ALOPECIA 10 0.0001
974 DRUG WITHDRAWAL SYNDROME 4 0.0000
975 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
976 DRUG DOSE OMISSION 7 0.0000
977 MIGRAINE 4 0.0000
978 DRUG DEPENDENCE 6 0.0000
979 PRODUCT DOSE OMISSION ISSUE 10 0.0000
980 NASOPHARYNGITIS 6 0.0000